Organovo Holdings (STU:4OR1) Total Stockholders Equity : €3.31 Mil (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Organovo Holdings Total Stockholders Equity?

Organovo Holdings's Total Stockholders Equity for the quarter that ended in Mar. 2024 was €3.31 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Organovo Holdings's Book Value per Share for the quarter that ended in Mar. 2024 was €0.33. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Organovo Holdings's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.39.

Organovo Holdings Total Stockholders Equity Historical Data

The historical data trend for Organovo Holdings's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organovo Holdings Total Stockholders Equity Chart

Organovo Holdings Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Stockholders Equity

Get a 7-Day Free Trial

24.10

32.93

27.43

14.32

3.31

Organovo Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															14.32	10.87	7.92	5.67	3.31

Organovo Holdings (STU:4OR1) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Organovo Holdings's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(3.313	-	0)	/	10.0777
	=	0.33

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Organovo Holdings's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.466	+	0.817)	/	3.313
	=	0.39

Organovo Holdings Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Organovo Holdings's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Organovo Holdings (STU:4OR1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Organovo Holdings Inc (STU:4OR1) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

ONVO:USA

Address

11555 Sorrento Valley road, Suite 100, San Diego, CA, USA, 92121

Website

https://www.organovo.com

Organovo Holdings Inc is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo's key instrument platform is the NovoGen Bioprinter. The firm's 3-D bioprinting technologies create tissues using living cells and biocompatible hydrogels.

Organovo Holdings (STU:4OR1) Headlines

No Headlines